Tag: Eli Lilly and Co

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

Fat cat? Weight-loss drugs may be coming for your overweight pet

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction

Healthy Returns: Employers aren’t expanding coverage of GLP-1 obesity drugs – many are finding ways around it

Dow hovers at 53,000 as chip stock weakness holds back market: Live updates

Healthy Returns: Walmart, CVS step in to help seniors navigate Medicare coverage of obesity drugs 

Cramer says this aerospace stock is significantly undervalued, sees 35% upside

Medicare will start covering obesity drugs for the first time. Here’s what patients should know

Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet